Strata Critical Medical, Inc.
SRTA· Nasdaq
SRTAStrata Critical Medical, Inc.
Source filing unavailable
| Metric | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|
| Revenue | $20.32M | — | — |
| Net Income | -$9.18M | -$100.16K | $99.14K |
| EPS Diluted | -$0.13 | -$0.01 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
